1. Home
  2. NFE vs NNNN Comparison

NFE vs NNNN Comparison

Compare NFE & NNNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo New Fortress Energy Inc.

NFE

New Fortress Energy Inc.

N/A

Current Price

$5.91

Market Cap

324.4M

Sector

Utilities

ML Signal

N/A

Logo Anbio Biotechnology Class A Ordinary Shares

NNNN

Anbio Biotechnology Class A Ordinary Shares

N/A

Current Price

$6.29

Market Cap

270.4M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
NFE
NNNN
Founded
2014
2021
Country
United States
Germany
Employees
N/A
N/A
Industry
Oil/Gas Transmission
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
324.4M
270.4M
IPO Year
2018
2023

Fundamental Metrics

Financial Performance
Metric
NFE
NNNN
Price
$5.91
$6.29
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
★ 2.0M
228.0K
Earning Date
11-20-2026
10-23-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
N/A
★ N/A
Revenue
★ $1,504,037,000.00
N/A
Revenue This Year
$108.26
N/A
Revenue Next Year
$3.52
N/A
P/E Ratio
★ N/A
$446.57
Revenue Growth
N/A
★ N/A
52 Week Low
$0.23
$5.13
52 Week High
$16.90
$51.33

Technical Indicators

Market Signals
Indicator
NFE
NNNN
Relative Strength Index (RSI) 53.71 43.64
Support Level $0.55 $5.13
Resistance Level $16.90 $6.95
Average True Range (ATR) 1.36 0.52
MACD -0.50 0.21
Stochastic Oscillator 4.39 66.48

Price Performance

Historical Comparison
NFE
NNNN

About NFE New Fortress Energy Inc.

New Fortress Energy Inc is an integrated gas-to-power company. Its business model spans the entire production and delivery chain from natural gas procurement and liquefaction to logistics, shipping, terminals, and conversion or development of a natural gas-fired generation. It has invested in floating, liquefied natural gas vessels to lower the cost of acquiring gas while securing a long-term supply for its terminals. Its segments include Terminals & Infrastructure, and Ships. It generates the majority of its revenue from the Terminals & Infrastructure segment.

About NNNN Anbio Biotechnology Class A Ordinary Shares

Anbio Biotechnology is a medical device company focused on in vitro diagnostics. The company's mission is to change the diagnostics market by personalizing and decentralizing the current diagnostic solutions for faster diagnosis to improve patient prognosis. The company proposes this by providing accessible and affordable diagnostic solutions globally at the forefront of science and offering laboratory, wellness, at-home, and point-of-care (POCT) in vitro diagnostic (IVD) solutions. The business planning is to focus on validating and commercializing the existing portfolio of in vitro diagnostic products, as well as generating additional data required to support regulatory submissions and compliance, including under frameworks such as the In Vitro Diagnostic Regulation (IVDR).

Share on Social Networks: